Respiratory physician Lutz Beckert considers chronic obstructive pulmonary disease management, including the prevention of COPD, the importance of smoking cessation and pulmonary rehabilitation, and the lifesaving potential of addressing treatable traits. He also discusses the logic of inhaler therapy, moving from single therapy to dual and triple therapy when indicated, as well as other aspects of management
Chief coroner opens joint inquiry into anti-epileptic medication deaths
This item is over 2 years old; some content may no longer be current
+Undoctored
Chief coroner opens joint inquiry into anti-epileptic medication deaths
Friday 6 December 2019, 09:47 AM

Chief Coroner Judge Deborah Marshall has opened a joint inquiry into four deaths linked to the anti-epileptic medication Logem, which contains the anticonvulsant drug lamotrigine.
Four deaths linked to the medication have been referred to the coroner in the past months.
“Because of the high public interest in these cases, and the effect on people’s wellbeing, I have decided to open a joint inquiry into these deaths to investigate the cause and circumstances and see if they could have been prevented in any way,” Judge Marshall says.
“My inquiry will look at whether the change in brand to Logem may have changed the seizure control and whether that contributed to the deaths.”